These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18354029)

  • 1. Role of remission clinics in the longitudinal treatment of CKD.
    Ruggenenti P; Perticucci E; Cravedi P; Gambara V; Costantini M; Sharma SK; Perna A; Remuzzi G
    J Am Soc Nephrol; 2008 Jun; 19(6):1213-24. PubMed ID: 18354029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
    Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
    Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Remission Clinic approach to halt the progression of kidney disease.
    ;
    J Nephrol; 2011; 24(3):274-81. PubMed ID: 21534237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
    Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
    Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen).
    Ruggenenti P; Perna A; Zoccali C; Gherardi G; Benini R; Testa A; Remuzzi G
    J Am Soc Nephrol; 2000 Jan; 11(1):88-96. PubMed ID: 10616844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
    Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
    Fried LF; Duckworth W; Zhang JH; O'Connor T; Brophy M; Emanuele N; Huang GD; McCullough PA; Palevsky PM; Seliger S; Warren SR; Peduzzi P;
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):361-8. PubMed ID: 19118120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
    Ruggenenti P; Perna A; Gherardi G; Garini G; Zoccali C; Salvadori M; Scolari F; Schena FP; Remuzzi G
    Lancet; 1999 Jul; 354(9176):359-64. PubMed ID: 10437863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving remission of proteinuria in childhood CKD.
    Ruggenenti P; Cravedi P; Chianca A; Caruso M; Remuzzi G
    Pediatr Nephrol; 2017 Feb; 32(2):321-330. PubMed ID: 27704256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.
    Ruggenenti P; Perna A; Remuzzi G;
    Kidney Int; 2003 Jun; 63(6):2254-61. PubMed ID: 12753315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia.
    Ruggenenti P; Perna A; Benini R; Bertani T; Zoccali C; Maggiore Q; Salvadori M; Remuzzi G
    J Am Soc Nephrol; 1999 May; 10(5):997-1006. PubMed ID: 10232685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?
    Tan J; Jaung R; Gamble G; Cundy T
    Diabetes Res Clin Pract; 2014 Jan; 103(1):63-70. PubMed ID: 24380605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for renal failure in children with non-glomerular nephropathies.
    Litwin M
    Pediatr Nephrol; 2004 Feb; 19(2):178-86. PubMed ID: 14685838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of proteinuria and estimated GFR to predict progression to ESRD or death for hospitalized chronic kidney disease patients.
    Ohashi Y; Sakai K; Tanaka Y; Mizuiri S; Aikawa A
    Ren Fail; 2011; 33(1):31-9. PubMed ID: 21219203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber MA; Franklin S; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T;
    Ann Intern Med; 2006 Feb; 144(3):172-80. PubMed ID: 16461961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy.
    Ruggenenti P; Perna A; Remuzzi G
    J Am Soc Nephrol; 2001 Dec; 12(12):2832-2837. PubMed ID: 11729254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.